Literature DB >> 17056597

Toll-like receptor 4 region Glu24-Lys47 is a site for MD-2 binding: importance of CYS29 and CYS40.

Chiaki Nishitani1, Hiroaki Mitsuzawa, Hitomi Sano, Takeyuki Shimizu, Norio Matsushima, Yoshio Kuroki.   

Abstract

Toll-like receptor 4 (TLR4) is a signaling receptor for lipopolysaccharide (LPS), but its interaction with MD-2 is required for efficient responses to LPS. Previous studies with deletion mutants indicate a critical role of the amino-terminal TLR4 region in interaction with MD-2. However, it is uncertain which region in the TLR4 molecule directly binds to MD-2. The purpose of this study was to determine a critical stretch of primary sequence in the TLR4 region that directly binds MD-2 and is critical for LPS signaling. The synthetic TLR4 peptide corresponding to the TLR4 region Glu(24)-Lys(47) directly binds to recombinant soluble MD-2 (sMD-2). The TLR4 peptide inhibited the binding of a recombinant soluble form of the extracellular TLR4 domain (sTLR4) to sMD-2 and significantly attenuated LPS-induced NF-kappaB activation and IL-8 secretion in wild type TLR4-transfected cells. Reduction and S-carboxymethylation of sTLR4 abrogated its association with sMD-2. The TLR4 mutants, TLR4(C29A), TLR4(C40A), and TLR4(C29A,C40A), were neither co-precipitated with MD-2 nor expressed on the cell surface and failed to transmit LPS signaling. These results demonstrate that the TLR4 region Glu(24)-Lys(47) is a site for MD-2 binding and that Cys(29) and Cys(40) within this region are critical residues for MD-2 binding and LPS signaling.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17056597     DOI: 10.1074/jbc.M606904200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

Review 1.  Macrophage activation by endogenous danger signals.

Authors:  X Zhang; D M Mosser
Journal:  J Pathol       Date:  2008-01       Impact factor: 7.996

Review 2.  Mycoplasma lipoproteins and Toll-like receptors.

Authors:  Ling-ling Zuo; Yi-mou Wu; Xiao-xing You
Journal:  J Zhejiang Univ Sci B       Date:  2009-01       Impact factor: 3.066

3.  A peptide antagonist of the TLR4-MD2 interaction.

Authors:  Peter F Slivka; Mitesh Shridhar; Gui-in Lee; Deanne W Sammond; Mark R Hutchinson; Alexander J Martinko; Madison M Buchanan; Page W Sholar; Jeffrey J Kearney; Jacqueline A Harrison; Linda R Watkins; Hang Yin
Journal:  Chembiochem       Date:  2009-03-02       Impact factor: 3.164

4.  Essential roles of hydrophobic residues in both MD-2 and toll-like receptor 4 in activation by endotoxin.

Authors:  Nusa Resman; Jozica Vasl; Alja Oblak; Primoz Pristovsek; Theresa L Gioannini; Jerrold P Weiss; Roman Jerala
Journal:  J Biol Chem       Date:  2009-03-24       Impact factor: 5.157

5.  The gene history of zebrafish tlr4a and tlr4b is predictive of their divergent functions.

Authors:  Con Sullivan; Jeremy Charette; Julian Catchen; Christopher R Lage; Gregory Giasson; John H Postlethwait; Paul J Millard; Carol H Kim
Journal:  J Immunol       Date:  2009-10-07       Impact factor: 5.422

Review 6.  Targeting Toll-like receptors with small molecule agents.

Authors:  Xiaohui Wang; Christina Smith; Hang Yin
Journal:  Chem Soc Rev       Date:  2013-06-21       Impact factor: 54.564

7.  Sequence-structure-function relations of the mosquito leucine-rich repeat immune proteins.

Authors:  Robert M Waterhouse; Michael Povelones; George K Christophides
Journal:  BMC Genomics       Date:  2010-09-30       Impact factor: 3.969

8.  Computational-Driven Epitope Verification and Affinity Maturation of TLR4-Targeting Antibodies.

Authors:  Bilal Ahmad; Maria Batool; Moon-Suk Kim; Sangdun Choi
Journal:  Int J Mol Sci       Date:  2021-06-01       Impact factor: 5.923

9.  Functional insights from the crystal structure of the N-terminal domain of the prototypical toll receptor.

Authors:  Monique Gangloff; Christopher J Arnot; Miranda Lewis; Nicholas J Gay
Journal:  Structure       Date:  2012-12-13       Impact factor: 5.006

Review 10.  Recognition of lipid A variants by the TLR4-MD-2 receptor complex.

Authors:  Nina Maeshima; Rachel C Fernandez
Journal:  Front Cell Infect Microbiol       Date:  2013-02-12       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.